Supplemental material
Cell Cycle
Volume 16, 2017 - Issue 19
Reports
Preclinical evaluation of the imipridone family, analogs of clinical stage anti-cancer small molecule ONC201, reveals potent anti-cancer effects of ONC212
Jessica WagnerLaboratory of Translational Oncology and Experimental Cancer Therapeutics, Molecular Therapeutics Program, Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA
http://orcid.org/0000-0003-2587-3310
http://orcid.org/0000-0003-2587-3310, Christina Leah KlineLaboratory of Translational Oncology and Experimental Cancer Therapeutics, Molecular Therapeutics Program, Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, PA, USAhttp://orcid.org/0000-0001-7764-0119
http://orcid.org/0000-0001-7764-0119, Marie D. RalffLaboratory of Translational Oncology and Experimental Cancer Therapeutics, Molecular Therapeutics Program, Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, PA, USAhttp://orcid.org/0000-0003-2113-0974
http://orcid.org/0000-0003-2113-0974, Avital LevLaboratory of Translational Oncology and Experimental Cancer Therapeutics, Molecular Therapeutics Program, Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, PA, USAhttp://orcid.org/0000-0002-2127-7338
http://orcid.org/0000-0002-2127-7338, Amriti LullaLaboratory of Translational Oncology and Experimental Cancer Therapeutics, Molecular Therapeutics Program, Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, PA, USAhttp://orcid.org/0000-0002-7085-5755
http://orcid.org/0000-0002-7085-5755, Lanlan ZhouLaboratory of Translational Oncology and Experimental Cancer Therapeutics, Molecular Therapeutics Program, Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, PA, USAhttp://orcid.org/0000-0001-9471-9099
http://orcid.org/0000-0001-9471-9099, , , , , , , & show allReprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
Related Research Data
Linking provided by
